Individual Patient Compassionate Use of GX-I7

Response-based Treatment of High-risk Neuroblastoma

NCT02771743 ·Status: UNKNOWN ·Phase: PHASE2

IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma

NCT05353530 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Vortioxetine for Newly Diagnosed Glioblastoma

NCT07284628 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

G207 Followed by Radiation Therapy in Malignant Glioma

NCT00157703 ·Status: COMPLETED ·Phase: PHASE1

A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases

NCT07268053 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)

NCT06806228 ·Status: SUSPENDED ·Phase: PHASE1

Low Dose Radiation Therapy for Glioblastoma Multiforme

NCT01466686 ·Status: COMPLETED ·Phase: PHASE2

Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor

NCT02784054 ·Status: UNKNOWN ·Phase: PHASE2

A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

NCT01280552 ·Status: COMPLETED ·Phase: PHASE2

Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.

NCT01301430 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma

NCT00190424 ·Status: COMPLETED ·Phase: PHASE2

Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine

NCT00074607 ·Status: TERMINATED ·Phase: PHASE1

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

NCT07346144 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Phase II Study to Treat Advanced Malignant Glioma

NCT00427440 ·Status: COMPLETED ·Phase: PHASE2

IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)

NCT06946680 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors

NCT02197169 ·Status: COMPLETED ·Phase: PHASE1

Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma

NCT04015700 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Phase 2 Study of BGJ398 in Patients With Recurrent GBM

NCT01975701 ·Status: COMPLETED ·Phase: PHASE2

High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma

NCT00283556 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation

NCT02481154 ·Status: COMPLETED ·Phase: PHASE1

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

NCT07301268 ·Status: RECRUITING ·Phase: PHASE2

A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients

NCT07185880 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients

NCT04121455 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT

NCT04763031 ·Status: TERMINATED ·Phase: NA

A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma

NCT05802693 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1